Department for Community Based Services

Standards of Practice Online Manual

30.21 KASPER Reports

Cabinet for Health and Family Services

Department for Community Based Services
Division of Protection and Permanency
Standards of Practice Online Manual
Chapter:
Chapter 30-Quality Assurance and Organizational Integrity
Effective:
3/15/2016
Section:
30.21 KASPER Reports
Version:
3

When a section of SOP has been revised users will see the following: Added {This is added material}, Deleted {This is deleted material}. The bold and strikethroughs will appear on the site for fifteen (15) days after a modification and will then be removed.

Legal Authority/Introduction

LEGAL AUTHORITY:

The Kentucky All Schedule Prescription Electronic Reporting (KASPER) system is the Commonwealth's prescription monitoring program.  The program monitors Schedule II, III, IV, and V controlled substance prescriptions dispensed within the Commonwealth (refer to Controlled Substances by Schedule and Generic Name).  A KASPER report shows all Schedule II-V controlled substance prescriptions an individual has had for a specified period of time, as well as the practitioner who prescribed them and the dispenser who dispensed them.  The program is administered by the Drug Enforcement and Professional Practices Branch (DEPPB) of the Cabinet for Health and Family Services (CHFS), Office of the Inspector General (OIG), Division of Fraud, Waste, Abuse/Identification and Prevention (DFWAIP).

Per KRS 218A.202 (6), DCBS staff are not authorized to obtain KASPER reports and the courts may not issue a court order for a KASPER report in a civil case.  Under no circumstance, should a DCBS worker possess a KASPER report.  Sharing KASPER data outside the provisions of KRS 218A.202(8) is a Class D Felony. KASPER reports are not to be placed in any DCBS case files. For details on KASPER, please refer to the KASPER (Kentucky All Schedule Prescription Electronic Reporting) web page.

The KASPER database has limitations that reduce the reliability of positive identification.  Therefore, no action shall be taken against an individual identified in a DCBS investigation until a DEPPB investigative report is received from a DEPPB investigator.

Interpretation of KASPER report data can only be done by a law enforcement officer trained in prescription controlled substance investigation.  DCBS staff do not have the authority or necessary training to appropriately verify or interpret the data on a KASPER report.  In cooperation with the Cabinet for Health and Family Services, Office of Inspector General, Division of Fraud, Waste and Abuse/Identification and Prevention, Drug Enforcement and Professional Practices Branch, a DEPPB investigative report may be provided to authorized DCBS staff. 

The DEPPB investigative report is only one tool in the assessment process and should not be used as the sole basis to substantiate a referral or remove children.

Procedure

The SSW:

  1. Seeks consultation from their FSOS to determine if there is a need to obtain a DEPPB investigative report;
  2. Seeks consultation with their regional attorney or Service Region Clinical Associate (SRCA) to determine if a DEPPB investigation is warranted if the FSOS agrees that a DEPPB investigative report is needed;
  3. Requests a DEPPB investigation by completing the steps below if the regional attorney or SRCA agree that there is a need for a DEPPB investigation:
    1. Completes a DPP-109 DEPPB Investigative Report Request;
    2. Assures the necessary written permissions are obtained; and
    3. Faxes the form to (502) 564-7468, to the attention of:

      Drug Enforcement and Professional Practices (DEPPB)
      Branch Manager
      Office of the Inspector General
      Cabinet for Health and Family Services
  4. Provides a written copy of the DEPPB investigative report to the FSOS, SRCA and/or regional attorney after receiving it from the DEPPB investigator;
  5. Consults with the DPP Medical Support Section of central office at (502) 564-6852 if assistance is needed in interpreting the DEPPB investigative report;
  6. Documents in the assessment, the results of the DEPPB investigative report, if an investigation is pending;
  7. Documents the results of the DEPPB investigative report in the service recordings for ongoing cases.

Practice Guidance

  • Examples of misuse may include a Schedule II-IV controlled substance prescription(s) that: 
    • Is being used for a non-medical reason;
    • Is acquired and taken by client for whom the medication was not prescribed;
    • Was obtained through deception; or
    • Is being taken in an amount that exceeds the prescribed dosage.
    •  DEPPB staff are available to consult with the FSOS or SSW regarding the findings of the DEPPB   investigative report. 

 

 

Communicate

Sign In (Editor Access Only)
Copyright © 2011 Commonwealth of Kentucky - All Rights Reserved
Kentucky Unbridled Spirit